Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2566 stock hub

HKG/2566 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2566is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2566

In the news

Latest news · HKG/2566

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E11.1

P25 10.7P50 17.9P75 38.5

ROE8.7

P25 -14.7P50 2P75 9.4

ROIC11.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2566 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

CNY

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	1,794
Employees Change	253%
Employees Change Percent	16.42
Enterprise value	HKD 1.1B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	HKD 1.7B
Price	HKD 6.99
Price currency	HKD
Rev Per Employee	810,292.72x
Sector	Healthcare
Sic	2836
Symbol	hkg/2566
Website	https://www.china-gene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.12%
EV Earnings	6.97x
EV/EBIT	6.82x
EV/EBITDA	5.38x
EV/FCF	4.7x
EV/Sales	0.74x
FCF yield	13.53%
P/B ratio	0.92x
P/E ratio	11.14x
P/S ratio	1.16x
PE Ratio3 Y	13.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.82%
EBITDA Margin	13.64%
FCF margin	15.71%
Gross margin	80.69%
Gross Profit	HKD 1.2B
Gross Profit Growth	-1.15%
Gross Profit Growth Q	-2.27%
Gross Profit Growth3 Y	1.71%
Gross Profit Growth5 Y	2.09%
Net Income	HKD 154M
Net Income Growth	-0.14%
Net Income Growth Q	45.05%
Net Income Growth3 Y	2.44%
Net Income Growth5 Y	3%
Pretax Margin	12.36%
Profit Margin	10.6%
Profit Per Employee	HKD 85,853
ROA	4.37
ROCE	7.91
ROE	8.74
ROIC	11.05
Roic5y	11.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.57%
EPS Growth	-16.89
EPS Growth Q	23.21
EPS Growth3 Y	-4.32
EPS Growth5 Y	-1.13
FCF Growth	157.56%
FCF Growth Q	102.66%
FCF Growth3 Y	20.72%
FCF Growth5 Y	72.13%
OCF Growth	168.86%
OCF Growth Q	125.79%
OCF Growth3 Y	23.12%
OCF Growth5 Y	30.42%
Revenue Growth	-4.59x
Revenue Growth Q	0.11x
Revenue Growth3 Y	-0.51x
Revenue Growth5 Y	-0.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.65
Assets	HKD 2.4B
Cash	HKD 795.1M
Current Assets	HKD 1.7B
Current Liabilities	HKD 382.8M
Debt	HKD 179.9M
Debt EBITDA	HKD 0.9
Debt Equity	HKD 0.1
Debt FCF	HKD 0.79
Equity	HKD 1.8B
Interest Coverage	24.96
Liabilities	HKD 522.7M
Long Term Assets	HKD 648.9M
Long Term Liabilities	HKD 140M
Net Cash	HKD 615.2M
Net Cash By Market Cap	HKD 36.44
Net Cash Growth	12.67%
Net Debt EBITDA	HKD -3.1
Net Debt Equity	HKD -0.34
Net Debt FCF	HKD -2.69
Tangible Book Value	HKD 1.8B
Tangible Book Value Per Share	HKD 7.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.46
Inventory Turnover	1.66
Net Working Capital	HKD 540M
Quick ratio	3.97
Working Capital	HKD 1.3B
Working Capital Turnover	HKD 1.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.16%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	HKD 0.07
Dividend Years	1
Dividend Yield	0.94%
Ex Div Date	2026-06-17
Last Dividend	HKD 0.06
Payout Ratio	9.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.55%
200-day SMA	9.41
50-day SMA	7.58
50-day SMA vs 200-day SMA	50under200
All Time High	16.29
All Time High Change	-57.09%
All Time High Date	2025-08-18
All Time Low	5.18
All Time Low Change	34.94%
All Time Low Date	2025-01-13
ATR	0.26
Beta1y	1.44
Beta2y	1.24
Ch YTD	-7.54
High	6.99
High52	16.29
High52 Date	2025-08-18
High52ch	-57.09%
Low	6.76
Low52	5.9
Low52 Date	2025-05-08
Low52ch	18.48%
Ma50ch	-7.83%
Price vs 200-day SMA	-25.7%
RSI	42.7
RSI Monthly	52.75
RSI Weekly	39.36
Sharpe ratio	0.52x
Sortino ratio	1.09
Total Return	-19.22%
Tr YTD	-7.54
Tr1m	1.01%
Tr1w	-2.24%
Tr3m	-30.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 157.2M
Operating Income Growth	14.23
Operating Income Growth Q	54
Operating Income Growth3 Y	-2.3
Operating Income Growth5 Y	1.64
Operating margin	10.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	40,661,259%
Net Borrowing	-24,382,044.5
Shares Insiders	0.97%
Shares Institutions	0.52%
Shares Out	241,516,400
Shares Qo Q	0%
Shares Yo Y	20.16%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 222.2M
Average Volume	38,710x
Bv Per Share	7.47
CAPEX	HKD -55.2M
Ch1m	1.01
Ch1w	-2.24
Ch1y	18.88
Ch3m	-30.31
Ch6m	-6.8
Change	1.9%
Change From Open	1.9
Close	6.86
Days Gap	0
Depreciation Amortization	42,538,739.1
Dollar Volume	352,296
Earnings Date	2026-05-18
EBIT	HKD 157.2M
EBITDA	HKD 198.4M
EPS	HKD 0.63
F Score	4
FCF	HKD 228.4M
FCF EV Yield	21.29x
FCF Per Share	HKD 0.95
Financing CF	-43,895,913
Fiscal Year End	December
Founded	1,993
Graham Number	10.27372
Graham Upside	46.98
Income Tax	HKD 25.7M
Investing CF	-450,211,868
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Lynch Fair Value	HKD 3.14
Lynch Upside	-55.1
Ma150	8.47
Ma150ch	-17.45%
Ma20	7.03
Ma20ch	-0.55%
Net CF	-210,274,399
Next Earnings Date	2026-05-18
Open	6.86
P FCF Ratio	7.39
P OCF Ratio	5.95
Payment Date	2025-07-30
Position In Range	100
Ppne	460,435,212.7
Price Date	2026-05-08
Price EBITDA	HKD 8.51
Ptbv Ratio	0.92
Relative Volume	1.3x
Revenue	1,453,665,140x
SBC By Revenue	0.42x
Share Based Comp	6,171,646
Tax By Revenue	1.77x
Tax Rate	14.31%
Tr6m	-6.8%
Volume	50,400
Z Score	4.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/2566 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.9%

$0.07 annual per share

Payout ratio

+9.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-19.2%

Next ex-dividend date: 2026-06-17

Performance

HKG/2566 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2566?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+20.2%

Negative means the company is buying back shares.

Technical

HKG/2566 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-25.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.52

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2566

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2566 stock rating?

hkg/2566 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2566 analysis?

The full report lives at /stocks/hkg/2566/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2566?

The latest report frames hkg/2566 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2566 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.